Screener
Sana Biotechnology SANA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $83,800 | $71,870 |
| Marketable securities | 17,336 | 66,512 |
| Restricted cash | 4,195 | 4,195 |
| Prepaid expenses and other current assets | 6,359 | 6,099 |
| Total current assets | 111,690 | 148,676 |
| Property and equipment, net | 25,673 | 26,906 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's short-term investments?
- Sana Biotechnology (SANA) reported short-term investments of $17.34M in Q1 2026.
- How has Sana Biotechnology's short-term investments changed year-over-year?
- Sana Biotechnology's short-term investments increased by 102.3% year-over-year, from $8.57M to $17.34M.
- What is the long-term trend for Sana Biotechnology's short-term investments?
- Over 5 years (2020 to 2025), Sana Biotechnology's short-term investments has grown at a -23.5% compound annual growth rate (CAGR), from $253.46M to $66.51M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Sana Biotechnology's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude